Research output per year
Research output per year
Personal profile
Headline
PROFESSOR | Surgery
Fingerprint
Dive into the research topics where Myron Schwartz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
Llovet, J. M., Pinyol, R., Yarchoan, M., Singal, A. G., Marron, T. U., Schwartz, M., Pikarsky, E., Kudo, M. & Finn, R. S., Apr 2024, In: Nature Reviews Clinical Oncology. 21, 4, p. 294-311 18 p.Research output: Contribution to journal › Review article › peer-review
38 Scopus citations -
Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma
Huang, D. Q., Hoang, J. K., Kamal, R., Tsai, P. C., Toyoda, H., Yeh, M. L., Yasuda, S., Leong, J., Maeda, M., Huang, C. F., Won Jun, D., Ishigami, M., Tanaka, Y., Uojima, H., Ogawa, E., Abe, H., Hsu, Y. C., Tseng, C. H., Alsudaney, M. & Yang, J. D. & 13 others, , 1 Mar 2024, In: Journal of Clinical Oncology. 42, 7, p. 790-799 10 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Cholangiocarcinoma, sequential chemotherapy, and prognostic tests
Bruckner, H. W., De Jager, R., Knopf, E., Bassali, F., Book, A., Gurell, D., Nghiem, V., Schwartz, M. & Hirschfeld, A., 2024, In: Frontiers in Oncology. 14, 1361420.Research output: Contribution to journal › Article › peer-review
Open Access -
Early post-treatment MRI predicts long-term hepatocellular carcinoma response to radiation segmentectomy
Stocker, D., King, M. J., Homsi, M. E., Gnerre, J., Marinelli, B., Wurnig, M., Schwartz, M., Kim, E. & Taouli, B., Jan 2024, In: European Radiology. 34, 1, p. 475-484 10 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Hepatic Resection for Hepatocellular Carcinoma
Tabrizian, P., Pero, A. & Schwartz, M., 2024, (Accepted/In press) In: Clinics in Liver Disease.Research output: Contribution to journal › Review article › peer-review
Press/Media
-
Findings from Icahn School of Medicine at Mount Sinai Provides New Data on Liver Cancer (Improved Outcomes of Liver Resection for Hepatitis C-related Hepatocellular Carcinoma After the Introduction of Direct-acting Antiviral Therapy)
Rocha, C., Amodeo, S., Tabrizian, P., Schwartz, M., Florman, S., Schiano, T. & Facciuto, M.
30/08/24
1 item of Media coverage
Press/Media
-
Investigators at Icahn School of Medicine at Mount Sinai Discuss Findings in Liver Cancer [Intratumoral Dendritic Cell-cd4(+) T Helper Cell Niches Enable Cd8(+) T Cell Differentiation Following Pd-1 Blockade In Hepatocellular Carcinoma]
Hegde, S., Lavin, Y., Merad, M., Kim-Schulze, S., D'Souza, D., Hamon, P., Dawson, T., Tsankov, A., Rahman, A., Schwartz, M., Gnjatic, S., Ward, S., Kamphorst, A. O. & Giotti, B.
29/08/23
1 item of Media coverage
Press/Media
-
Findings from Icahn School of Medicine at Mount Sinai Broaden Understanding of Liver Cancer [Abstract 2178: Circulating tumor DNA (ctDNA) correlates closely with tumor necrosis and relapse-free survival (RFS) in hepatocellular carcinoma (HCC) ...]
Merad, M., Kim, E., Schwartz, M., Fiel, M., Gnjatic, S., Ward, S., Kamphorst, A. O., Bhardwaj, N. & Hamon, P.
26/06/23
1 item of Media coverage
Press/Media
-
Study Published in Nature Medicine Highlights use of Vizgen MERSCOPE® Platform for Understanding Effects of Neoadjuvant Immunotherapy for Patients with Hepatocellular Carcinoma (HCC)
Merad, M., Schwartz, M., Marron, T. & Hamon, P.
19/06/23 → 20/06/23
8 items of Media coverage
Press/Media